🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

JOHN OLIVER ON GABRIELLE HANSON: “In a world that makes sense she’s resign in shame… far-right Republicans have a Vice grip on the party.” He says we need more “nosy bitches” in the media like @NC5PhilWilliams is now @PhilNvestigates 🎯 🎯 — AMEN! City of Franklin rawstory.com/right-wing-rep…

1. There are still a lot of people with very large microphones talking about the violent "crime wave" sweeping the United States But yesterday, the FBI released nationwide crime data for 2022 that tells a very different story 🧵

👉The only vote not for Trump is a vote for Biden.

Dear MAGAs Trump's greatest lie was in convincing you, he was like you. You haven't done these things.

#Didyouknow CTTC's Innovation Ambassadors Program is helping faculty bridge the gap between #research & #entrepreneurship. With a designated Ambassador from each department, faculty can easily access information on commercialization, IP, and more. ow.ly/39J850O5tJ0

Congrats to Rachael and Steven!!

One of the monoclonal antibodies in the therapeutic Evusheld has been computationally redesigned to restore its action against Omicron variants of the virus that causes COVID-19. nature James Crowe @VUMC_Vaccines spr.ly/6011jIrWS

Check our recent publication about how the antibody response to Omicron-based boosters in humans is imprinted by immunizations with historical mRNA-1273 vaccines. Congrats to Chieh-Yu! #WUSM #COVID nature.com/articles/s4158…

You will be greatly missed!

Very excited about this next round of pressure-testing our pandemic response capabilities. New approaches and upgrades to try out. Hantaviruses also present unique hurdles we did not face with SARS-CoV-2. Looking forward to seeing our team meet the challenge! #VVCHantaSprint

nature.com/articles/s4156… We are very excited to share our new story, published in Nature Microbiology, detailing mAbs that potently neutralize human parainfluenza virus 3 in vitro and offer complete protection in vivo. @VUMC_Vaccines

Our JPL CBRND EB supports @VUMC_Vaccines' efforts to find a Hantavirus vaccine. Partnerships like this enable us to develop medical countermeasures to protect our warfighters from any biological threat. Follow #VVCHanthaSprint for the latest research updates.

Vanderbilt’s Innovation Ambassadors help their colleagues change the world 🚀🔬In the heart of Vanderbilt's intellectual powerhouse lies a force of visionaries, inventors, & entrepreneurs shaping the future of medicine & technology💡#VanderbiltInnovation ow.ly/C3Lb50RrfxC

Jealous that the VVC is sprinting on hantas without me! Follow along if you’re like me and love hanta antibodies!! 🦠 DARPA JPEO-CBRND

Exciting news about a truly important antibody drug discovered right here in the @VUMC_Vaccines.

SUCH important work— practicing to prevent the next pandemic! We’re proud to be part of the sprint to determine how fast #hanta defeating antibodies can be discovered. @VUMC_Vaccines— your DNA is on the way! 🧬—>📦 #VVCHantaSprint Twist Bioscience

I love it when a plan comes together!

Love to see our wicked smart friends over at RenBio continuing to do great things!

Our newest collab with the DoD to stop pandemics before they start. We will bank validated solutions to pandemic potential pathogens while also further expanding our lightning-fast response platform. (Both approaches are essential). @VUMC_Vaccines news.vumc.org/2024/08/13/vum…

A potently #neutralizing and protective human #antibody with a unique antigenic footprint on #RSV and #hMPV fusion glycoproteins. Collaborative work with Jason McLellan Jarrod Mousa Rachel Bonami James Crowe Robert Carnahan, and others. biorxiv.org/content/10.110…